NK cells and ILCs in tumor immunotherapy.
Mol Aspects Med. 2021 Aug;80:100870. doi: 10.1016/j.mam.2020.100870. Epub 2020 Aug 13.
Mol Aspects Med. 2021.
PMID: 32800530
Free article.
Review.